Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | THAP8 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | CCP110 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | ZNF292 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-07 |
mRNA | ZNF571 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
mRNA | PDZD4 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-07 |
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-07 |
mRNA | BAX | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-07 |
mRNA | FKBP7 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
mRNA | ZNF135 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |